Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 313.00
-2.00 (-0.63%)
Aug 6, 2026, 11:30 AM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 11.35 billion as of August 5, 2026. Its market cap has decreased by -20.59% in one year.
Market Cap
11.35B
Enterprise Value
9.27B
Revenue
323.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
313.00
ChartMarket Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 11.35B, a decrease of -52.17%. That is a compound annual growth rate of -13.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 11.35B | 64.29% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CanBas | 13.95B |
| RaQualia Pharma | 12.55B |
| ReproCELL | 12.15B |
| SUSMED,Inc. | 12.00B |
| Kubota Pharmaceutical Holdings | 8.88B |
| Immuno-Biological Laboratories | 8.67B |
| CellSeed | 8.65B |
| K Pharma,Inc. | 8.35B |